title: Plasma cell CD20 expression: primary aberrant expression or receptor up-regulation.
authors.affiliation: Florida Hospital Cancer Institute , Orlando, FL , USA.
authors.forename: Bushra
authors.initials: B
authors.lastname: Ajaz
authors.forename: Adnan
authors.initials: A
authors.lastname: Akhtar
authors.forename: Chung-Che
authors.initials: CC
authors.lastname: Chang
authors.forename: Melhem
authors.initials: M
authors.lastname: Solh
authors.forename: Kay
authors.initials: K
authors.lastname: Tangonan
authors.forename: Yasser
authors.initials: Y
authors.lastname: Khaled
mesh_terms: D018951:Antigens, CD20 / Q000378:metabolism*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007150:Immunohistochemistry; D008875:Middle Aged; D009101:Multiple Myeloma / Q000188:drug therapy / Q000378:metabolism; D010950:Plasma Cells / Q000187:drug effects / Q000378:metabolism* / Q000473:pathology; D015854:Up-Regulation
chemical_list: D018951:Antigens, CD20